CTIS2024-511409-42-00进行中（未招募）1 期
Combination therapy of 5-Fluorouracil and Calcipotriol versus 5-Fluorouracil in the treatment of Actinic Keratosis: a multicentre randomized controlled clinical trial
niversity Hospital Maastricht0 个研究点目标入组 232 人开始时间: 2024年3月13日最近更新:
适应症
试验速览
- 阶段
- 1 期
- 状态
- 进行中（未招募）
- 发起方
- 入组人数
- 232
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional clinical trial of medicinal product
入排标准
- 年龄范围
- 18 至 65+（—）
- 性别
- All
入选标准
- •Adults above 18 years of age, Clinical and dermoscopical diagnosis of AK by a dermatologist, in one or more area(s): Face, ears, (balding) scalp OR Neck/Shawl area, including the sun-exposed chest area OR Upper extremities, Number of AK lesions =4 in a continuous treatment area of up to 100 cm2, AK Olsen grade I-III
排除标准
- •Previous field treatment for AK within 2cm of the treatment area, within 3 months, (non) melanoma skin cancer in treatment area, Mucosal lesions, Genetic skin cancer disorder, Women who are pregnant or breastfeeding, Previous allergy or intolerance to either 5Fluorouracil or calcipotriol, Patients with known contra-indications for calcipotriol use: previous diagnosis of hyper-calcemia, disturbed calcium metabolism, severe kidney or liver dysfunction, Concurrent use of oral capecitabine or any other topical or systemic chemopreventive agent for any indication, Limited understanding of the Dutch language and not being able to give informed consent
研究者
相似试验
进行中（未招募）
不适用
Combination of 5-Fluorouracil/Folinate/Oxaliplatin (Eloxatin®) (FLOX regimen) with Concomitant or Concomitant and Maintenance Administration of Cetuximab (Erbitux®), in First-Line Treatment of Metastatic Colorectal Cancer. - Nordic VIIPatient with metastatic colorectal cancer.EUCTR2005-000117-34-ISThe Nordic Colorectal Cancer Biomodulation Group550
进行中（未招募）
不适用
Combination of 5-Fluorouracil/Folinate/Oxaliplatin (Eloxatin®) (FLOX regimen) with Concomitant or Concomitant and Maintenance Administration of Cetuximab (Erbitux®), in First-Line Treatment of Metastatic Colorectal Cancer. - Nordic VIIPatient with metastatic colorectal cancer.EUCTR2005-000117-34-DKThe Nordic Colorectal Cancer Biomodulation Group550
进行中（未招募）
不适用
Combination of 5-Fluorouracil/Folinate/Oxaliplatin (Eloxatin®) (FLOX regimen) with Concomitant or Concomitant and Maintenance Administration of Cetuximab (Erbitux®), in First-Line Treatment of Metastatic Colorectal Cancer. - Nordic VIIPatient with metastatic colorectal cancer.EUCTR2005-000117-34-SEThe Nordic Colorectal Cancer Biomodulation Group550
已完成
不适用
Combination therapy of 5-Fluorouracil/gemcitabine/cisplatin for advanced hepatocellular carcinoma with extrahepatic metastases -A pilot studyHepatocellular carcinoma with extrahepatic metastasesJPRN-UMIN000000719Hiroshima University5
撤回
2 期
Immunotherapy After Transplantation for Skin Cancer Prevention in Organ Transplant RecipientsImmunotherapyCutaneous Squamous Cell CarcinomaActinic KeratosesOrgan Transplant RecipientsSkin CancerNCT04642287Massachusetts General Hospital64